SkinRex issued FDA warning letter

January 8, 2014 by Chris Walker

SkinRex has been issued a FDA warning letter, concerning its marketing of Cavi-Lipo without approval or clearance.

SkinRex issued FDA warning letter

Korean cosmetic medical device company SkinRex Co. is in hot water with the FDA after the federal watchdog agency issued a warning letter over the marketing of its Cavi-Lipo device.

Seoul-based Skinrex is focused on skincare and weight issues. The company, founded in 2002, is led by Se-Yeong Choi and markets 3 products.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp